Savara Inc (SVRA)
Savara Inc (SVRA) from its SEC filings: 2020 revenue $257,000, net margin -19305%, free cash flow -$39.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2020) | $257,000 |
| Net income | -$49.6 million |
| Net margin | -19305.4% |
| Free cash flow | -$39.9 million |
| Latest quarter (Q3 2021 (calendar)) revenue vs a year earlier | -100% |
| Cash | $41.8 million |
| Long-term debt | $30.1 million |
| Share count, 1 year | +19% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.